SOLIGENIX, INC. Class of Warrant or Right, Outstanding
SOLIGENIX, INC. (SNGX) had Class of Warrant or Right, Outstanding of 261.25 thousand shares as of 2016-12-31, per its 10-K filed 2017-03-27.
Discontinued › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2017-03-27
- 2016-12-31: Class of Warrant or Right, Outstanding 261.25K shares.
- 2014-12-31: Class of Warrant or Right, Outstanding 586.08K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2016-12-31 | 261.25K shares 10-K · filed 2017-03-27 |
| 2014-12-31 | 586.08K shares 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |